FindTrial
Sign In

A randomized controlled trial of triamcinolone intravitreal injection versus vitrectomy for diabetic macular edema.

A randomized controlled trial of triamcinolone intravitreal injection versus vitrectomy for diabetic macular edema. - A trial of triamcinolone intravitreal injection versus vitrectomy for diabetic macular edema.

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-C000000432
Enrollment
20
Registered
2006-06-21
Start date
2006-06-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with diabetic macula edema.

Interventions

4 mg triamcinolone intravitreal injection vitrectomy

Sponsors

Faculty of medicine, Kagoshima university graduate school of medicine and dental sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1)Patients with type 2 diabetes mellitus (2)HbA1c less than 10% (3)Foveal thickness more than 300 micron m on OCT3000 (4)Visual acuity of 0.3-1.0 logMAR

Exclusion criteria

Exclusion criteria: Exclusion criteria were: (1)active proliferatve diabetic retinopathy: (2) previous vitreoretinal surgery; (3) treatment of laser photocoagulation within 3 months; (4) other treatments for diabetic macular edema within 3months; (5) a history of glaucoma and ocular hypertention

Design outcomes

Secondary

MeasureTime frame
Best correlate visual acuity—

Primary

MeasureTime frame
Foveal thickness using optical coherent tomography—

Countries

Japan

Contacts

Public ContactNorihito Doi

Faculty of medicine, Kagoshima university graduate school of medicine and dental sciences Department of ophthalmology

doi@m3.kufm.kagoshima-u.ac.jp099-275-5402

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026